topotecan

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

topotecan

Jul 11, 2024, 09:55 | Insight

Piotr Wysocki: Tisotumab vedotin improves outcomes of patients with recurrent cervical cancer

Piotr Wysocki recently posted on LinkedIn: "Vergote I et al. published results of a phase III…

Jul 3, 2024, 14:37 | Insight

Jarushka Naidoo: Phase III RESILIENT Trial of Liposomal Irinotecan v Topotecan in 2L SCLC

Jarushka Naidoo shared a post on X: “Phase III RESILIENT Trial of Liposomal Irinotecan v…

Apr 26, 2024, 20:26 | Insight

New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial

Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…

Apr 25, 2024, 12:40 | Drugs

Piotr Wysocki: Similar activity of topotecan and liposomal irinotecan in second-line treatment of SCLC

Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…

Sep 4, 2023, 16:27 | Drugs

Guillermo Chantada: Great study of an animal model for testing the orbital disposition of topotecan after intra-arterial administration.

Guillermo Chantada, the President of SIOP, recently shared a post by IOVC Journal on X/Twitter,…

All: 5 Posts: 1 - 100